医院收购感染治疗市场份额，规模，趋势，行业分析报告，用药物阶层（抗菌药物{细胞壁合成抑制剂，蛋白质合成抑制剂，其他}，抗病毒药物，抗真菌药物）;通过感染类型;按地区;分部预测，2021 - 2028

Report Summary

The global hospital acquired infections therapeutic market was valued at USD 10.45 billion in 2020 and is expected to grow at a CAGR of 2.3% during the forecast period. The key factors responsible for the hospital acquired infections therapeutic market growth include the increasing prevalence of hospital acquired infections, approval of new drug therapies to contain such illnesses and surge in infectious diseases over the past decade.

Know more about this report:请求样本页面

医院疾病也被称为医院获得的感染（HAI）主要由病毒，真菌和细菌病原体引起的医疗保健设施中的药物或医疗。betway体育亚洲版入口最常见的感染包括外科手术部位，呼吸机相关，泌尿道和血流疾病。提高患病率和缺乏合理的数据，显着推动了对医院获得的感染治疗市场的需求。

As per the study done by Organization for Economic Co-operation and Development (OECD), in 2018, there were around 3.8 million people in the European Union who have been diagnosed by hospital acquired illnesses in the acute care facilities. Moreover, OECD also estimated that each year approximately 90,000 people in Europe died by hospital acquired infections.

However, there is a gradual decline in the occurrence rate of hospital acquired infections in several lethal types, in emerging countries. According to the report published by CDC, in 2018, hospital acquired infections in the acute care hospital in the U.S. declined, it reported a 9% decline in bloodstream infections, 8% decline in urinary tract infections, and 12% decline in clostridium infections.

这种下降主要是由于专门的监管规范和医疗专业人士的认识的共同努力。德国，法国，英国和美国等发达国家拥有专门的医疗设施，可以轻松地遵守严格的政策制度。因此，在发达经济体中，对医院的需求的下降具有严格的预防措施可能会阻碍治疗性市场增长。

医院获得的感染治疗市场报告范围

The market is primarily segmented on the basis of drug class, by infection type, and geographic region.

By Drug Class	通过感染类型	By Region
抗菌药物 细胞壁合成抑制剂 蛋白质合成抑制剂 其他 抗病毒药物 Anti-fungal Drugs	尿路感染 呼吸机相关的肺炎 Surgical Site 血统 其他医院	North America (U.S., Canada) Europe (France, Germany, UK, Italy, Spain, Netherlands, Austria) 亚太（日本，中国，印度，马来西亚，印度尼西亚，韩国） Latin America (Brazil, Mexico, Argentina) Middle East & Africa (Saudi Arabia, UAE, Israel, South Africa)

Know more about this report:请求样本页面

感染类型的洞察力

手术部位获得了2020年治疗市场的最大收入份额的疾病。这一高度归因于手术人数增加，增加医院入学，随后的手术部位感染。

根据CDC发布的统计数据，在一年内进行了大约2700万辆的手术，其中5％的住院患者患者发生了外科遗址感染。每年在该国约有30万名患者受此类感染的影响。SSIS还将住院时间从7到11天增加，预计将花费约3,000美元。

However, the urinary tract infections (UTIs) acquired in hospitals is projected to witness the highest growth rate over the assessment period. Growing patient awareness about the condition in emerging countries, and the rising cases of UTIs. UTIs are more common in women, around 40% of them experience a case of UTIs, at some time in their life. Moreover, the launch of new drugs to contain UTIs also favoring the segment’s market growth prospects for therapeutic.

药物课程洞察力

In 2020, the antibacterial drugs market segment accounted for the largest revenue share of the therapeutic market. Such dominance is attributed to the fact that majority of the hospital acquired infections were bacterial in origin and research and innovation in the sector. Hence, a large proportion of hospital acquired infections was treated with such antibacterial drugs.

此外，抗细菌治疗剂被认为是治疗医院获得感染的金标准。多药微生物应用广谱抗生素治疗，并发症很小。理想的抗细菌疗法应短至7天，与14至21天相比。

地理概述

地理位置,医院acq的全球市场uired infections therapeutic is bifurcated into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa (MEA). Europe market is the largest revenue contributor followed by North America and the Asia Pacific region.

2020年，欧洲市场占全球治疗性市场的30％以上。负责此类增长的区域因素包括该地区的医院收购感染的高患病率，治疗药物的强劲管道，以及该行业的商业活动增加。此外，该地区行业巨头的存在也支持市场增长。

Competitive Insight

The prominent players operating in the market for hospital acquired infections therapeutic are Merck, Abbott Laboratories, Pfizer Inc., GlaxoSmithKline Plc., Bayer AG, AbbVie Inc., F. Hoffmann-La Roche Ltd, Daiichi Sankyo Company, Limited and Allergan Plc. The companies in the market are adopting growth strategies by introducing new product in the market; through mergers & acquisitions and joints ventures; and by tapping into new geographical territories.